Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)

Summary

A Randomized Controlled Multicenter Clinical Trial, Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®) and Standard of Care versus Standard of Care alone in the healing Chronic Diabetic Foot Ulcers. Multi-center, open label, randomized controlled trial. Study is estimated to require 12 months from first subject enrolled to last subject visit.

Timeline

Start

2020-09-01

Primary completion

2022-03-01

Completion

2023-03-31

Drugs

Indications